Addex Therapeutics (ADXN) EBT Margin: 2022-2025
Historic EBT Margin for Addex Therapeutics (ADXN) over the last 3 years, with Jun 2025 value amounting to 0.22%.
- Addex Therapeutics' EBT Margin rose 126393.00% to 0.22% in Q2 2025 from the same period last year, while for Jun 2025 it was 1.06%, marking a year-over-year increase of 45582.00%. This contributed to the annual value of -1,214.88% for FY2024, which is 105987.00% down from last year.
- According to the latest figures from Q2 2025, Addex Therapeutics' EBT Margin is 0.22%, which was down 88.26% from 1.88% recorded in Q1 2025.
- Addex Therapeutics' EBT Margin's 5-year high stood at 1,071.63% during Q4 2022, with a 5-year trough of -78,901.26% in Q4 2024.
- In the last 3 years, Addex Therapeutics' EBT Margin had a median value of -369.46% in 2023 and averaged -8,461.51%.
- Per our database at Business Quant, Addex Therapeutics' EBT Margin surged by 351,438bps in 2023 and then crashed by 7,831,605bps in 2024.
- Addex Therapeutics' EBT Margin (Quarterly) stood at 1,071.63% in 2022, then slumped by 165,684bps to -585.21% in 2023, then tumbled by 7,831,605bps to -78,901.26% in 2024, then soared by 126,393bps to 0.22% in 2025.
- Its EBT Margin was 0.22% in Q2 2025, compared to 1.88% in Q1 2025 and -78,901.26% in Q4 2024.